135 Real world outcomes for “intermediate-high” mortality risk patients presenting with submassive pulmonary embolism in a tertiary cardiothoracic centre
Paul Brennan(National Cancer Institute of Thailand), Ganesh Manoharan(University of Ulster), Jaimie Coburn(Institute of Cardiology), Kathy Cullen(Respiratory Clinical Trials), T.J. Warke(Respiratory Clinical Trials), Nicola Johnston(University of Ulster), Mark Spence(Mater Private Hospital), Dean Carolan(Institute of Cardiology), Damian McCall(Institute of Cardiology), Julian Leggett(Respiratory Clinical Trials)
Cited by 1
Related Papers
Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
|Journal of the American College of Cardiology|2013|643
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study
|The Lancet|1998|398
Multicenter Evaluation of a Next-Generation Balloon-Expandable Transcatheter Aortic Valve
|Journal of the American College of Cardiology|2014|317
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology
|Circulation Arrhythmia and Electrophysiology|2019|286